Shoe Zone (SHOE) announced that trading has continued positively throughout July and as a result of this, cash and equivalents as at 25 July 2026 stood at approximately £7.0m ahead of original budget. The
RNS Hotlist with Zak Mir: GNIP, OMI, WSBN, EOG, MPAL, SNDA, CPAI, OVB, EST, ECR, TEK, PXC, GDP, SWT, HEMO, SUS, AFC & RMR
GenIP (GNIP), the AI-powered innovation intelligence and technology commercialisation company, reported continued momentum across corporate and academic markets, building on the operational progress detailed in its January Corporate Update and reflecting
Share Talk Weekly Stock Market News Review, Sunday 2nd November 2025
UK stock markets closed lower on Friday, easing back after a record-breaking October rally as investors adopted a more cautious stance ahead of the Bank of England’s monetary policy decision and the Government’s Budget this month.
RNS Hotlist with Zak Mir: ACG, INSG, 80M, COBR, SNOX, ARV, ASTR, SYM, HEMO, NXT, GMET, ECOR, JNEO & PAT
Yesterday: ACG Metals (ACG) targets copper, zinc output by mid-2026, CEO says | Hotter Commodities. ACG Metals expects to begin to produce copper and zinc concentrates in mid-2026, marking a shift from
Hemogenyx Cleared to Advance CAR-T Therapy Trial After Positive Safety Review
Hemogenyx Pharmaceuticals (LON: HEMO) has received clearance from its independent Data Safety Monitoring Board (DSMB) to proceed to the next adult dose level in its Phase I clinical trial of
RNS Hotlist with Zak Mir: AML, WSBN, SWC, FMET, HUI, ITM, UKOG, EPP, ROCK, TAP, HEMO, EARN & ALK
The Times: Specialist small business lender Shawbrook has announced plans to float on the London Stock Exchange — providing a further boost to the London market.
Share Talk Weekly Stock Market News Review, Sunday 28th September 2025
The broader market was quiet for small-cap stocks this week. The AIM All-Share index rose slightly, gaining fewer than two points to close at 775.68. This was a marginal outperformance
RNS Hotlist with Zak Mir: OCDO, TAP, AST, EGT, KIST, TRT, RPI, AAI & HEMO
The Telegraph: Ocado’s grand ambitions threaten to end in disaster
Hemogenyx Pharmaceuticals (LON: HEMO) Letter of Intent with Cellin Technologies
Hemogenyx Pharmaceuticals Signs Letter of Intent with Cellin Technologies to Advance Commercialization of HG-CT-1 CAR-T Therapy in Estonia First Potential Near-Term Revenue Opportunity
Share Talk Weekly Stock Market News Review, Sunday 21st September 2025
London’s blue-chip FTSE 100 index closed 11 points lower at 9,216 on Friday, leaving it down around 0.7% for the week. The FTSE 250 mid-cap index shed 0.6%, with Raspberry
RNS Hotlist with Zak Mir: EEE, PALM, FMET, COBR, LEX, PREM, AMS, HEMO, REE, TRU, NXQ, GFRD, HERC, MOON, QED, FDBK, ZEN, GST, FAB & SOLG
Yesterday, Empire Metals Limited (EEE), the resource exploration and development company, said it would like to respond to recent sharp decline in the Company’s share price and would like to clarify that
Hemogenyx Shares Surge 26% on Positive Phase I CAR-T Trial Update for AML
Hemogenyx Pharmaceuticals has announced encouraging progress in its Phase I clinical trial of HG-CT-1, a CAR-T cell therapy targeting relapsed/refractory acute myeloid leukemia (AML) in adults.